AR246745A1 - Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables. - Google Patents

Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables.

Info

Publication number
AR246745A1
AR246745A1 AR90318034A AR31803490A AR246745A1 AR 246745 A1 AR246745 A1 AR 246745A1 AR 90318034 A AR90318034 A AR 90318034A AR 31803490 A AR31803490 A AR 31803490A AR 246745 A1 AR246745 A1 AR 246745A1
Authority
AR
Argentina
Prior art keywords
glycosyl
compound
procedure
optical
eterified
Prior art date
Application number
AR90318034A
Other languages
English (en)
Spanish (es)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of AR246745A1 publication Critical patent/AR246745A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR90318034A 1989-10-10 1990-10-09 Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables. AR246745A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89402794A EP0422307A1 (en) 1989-10-10 1989-10-10 Novel alpha-glucosidase inhibitors

Publications (1)

Publication Number Publication Date
AR246745A1 true AR246745A1 (es) 1994-09-30

Family

ID=8202997

Family Applications (1)

Application Number Title Priority Date Filing Date
AR90318034A AR246745A1 (es) 1989-10-10 1990-10-09 Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables.

Country Status (21)

Country Link
US (1) US5097023A (cg-RX-API-DMAC10.html)
EP (2) EP0422307A1 (cg-RX-API-DMAC10.html)
JP (1) JP3032266B2 (cg-RX-API-DMAC10.html)
KR (1) KR0183012B1 (cg-RX-API-DMAC10.html)
CN (1) CN1029974C (cg-RX-API-DMAC10.html)
AR (1) AR246745A1 (cg-RX-API-DMAC10.html)
AT (1) ATE109153T1 (cg-RX-API-DMAC10.html)
AU (1) AU632855B2 (cg-RX-API-DMAC10.html)
CA (1) CA2027276C (cg-RX-API-DMAC10.html)
DE (1) DE69011033T2 (cg-RX-API-DMAC10.html)
DK (1) DK0422975T3 (cg-RX-API-DMAC10.html)
ES (1) ES2060980T3 (cg-RX-API-DMAC10.html)
FI (1) FI101796B (cg-RX-API-DMAC10.html)
HU (1) HU209724B (cg-RX-API-DMAC10.html)
IE (1) IE64079B1 (cg-RX-API-DMAC10.html)
IL (1) IL95928A (cg-RX-API-DMAC10.html)
NO (1) NO174203C (cg-RX-API-DMAC10.html)
NZ (1) NZ235578A (cg-RX-API-DMAC10.html)
PT (1) PT95547B (cg-RX-API-DMAC10.html)
TW (1) TW225539B (cg-RX-API-DMAC10.html)
ZA (1) ZA907936B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504078A (en) * 1990-06-08 1996-04-02 Merrell Dow Pharmaceuticals Inc. α-glucosidase inhibitors
US5268364A (en) * 1991-12-12 1993-12-07 The Biomembrane Institute Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification
US5843921A (en) 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
US5605893A (en) * 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
JP3580900B2 (ja) * 1995-04-20 2004-10-27 ホクレン農業協同組合連合会 α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料
US5929037A (en) * 1995-06-07 1999-07-27 Alberta Research Council Modified α-D-Glcρ-(1-2)-α-D-Glcρ-(1-3)-α-D-Glcρ-analogues
EP0858335B1 (en) * 1995-09-08 2003-03-12 Novo Nordisk A/S 2-alkylpyrrolidines
WO1998009981A1 (en) * 1996-09-09 1998-03-12 Wisconsin Alumni Research Foundation Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity
US6534487B1 (en) 1999-08-03 2003-03-18 Childrens Hospital Los Angeles Methods for suppressing appetite and enhancing exercise and recovery
EP1270598A4 (en) * 1999-12-21 2003-05-02 Ajinomoto Kk PARTIAL ESTER OF CELLULOSE WITH NITROGEN CARBOXYLIC ACID AND PRODUCTION METHOD
JP4486792B2 (ja) * 2003-06-12 2010-06-23 学校法人近畿大学 環状オニウム化合物およびグルコシダーゼ阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.

Also Published As

Publication number Publication date
IE903613A1 (en) 1991-04-24
JPH03127797A (ja) 1991-05-30
FI101796B1 (fi) 1998-08-31
KR910007951A (ko) 1991-05-30
NZ235578A (en) 1992-10-28
AU632855B2 (en) 1993-01-14
ES2060980T3 (es) 1994-12-01
FI904965A0 (fi) 1990-10-09
NO174203B (no) 1993-12-20
CA2027276A1 (en) 1991-04-11
KR0183012B1 (ko) 1999-04-01
PT95547A (pt) 1991-08-14
US5097023A (en) 1992-03-17
EP0422975B1 (en) 1994-07-27
ATE109153T1 (de) 1994-08-15
DE69011033D1 (de) 1994-09-01
NO904372D0 (no) 1990-10-09
HU906389D0 (en) 1991-04-29
EP0422307A1 (en) 1991-04-17
IE64079B1 (en) 1995-07-12
CA2027276C (en) 2000-05-16
NO904372L (no) 1991-04-11
CN1050879A (zh) 1991-04-24
AU6375690A (en) 1991-04-18
IL95928A (en) 1994-08-26
DK0422975T3 (da) 1994-08-22
ZA907936B (en) 1991-08-28
NO174203C (no) 1994-04-06
IL95928A0 (en) 1991-07-18
HU209724B (en) 1994-10-28
TW225539B (cg-RX-API-DMAC10.html) 1994-06-21
DE69011033T2 (de) 1994-11-17
PT95547B (pt) 1998-02-27
EP0422975A1 (en) 1991-04-17
HUT55402A (en) 1991-05-28
FI101796B (fi) 1998-08-31
CN1029974C (zh) 1995-10-11
JP3032266B2 (ja) 2000-04-10

Similar Documents

Publication Publication Date Title
AR246745A1 (es) Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables.
BE904431A (fr) Nouveaux derives morpholino de la daunorubicine et de la doxorubicine.
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
MY103365A (en) 4-demethoxy-4-amino-anthracyclines
ES8502129A1 (es) Un procedimiento para la preparacion de compuestos de acidos biliares
KR830000911A (ko) X-선 콘트라스트제제의 살균된 주사용의 생리적으로 가능한 용액의 제조방법 및 x-선콘트라스트 제제 및 완충액
SE8204918L (sv) Nya 3-amino-pregn-5-en-derivat, deras salter, sett for framstellning och anvendning derav som lekemedel och kompositioner innehallande dem
KR900018048A (ko) 환 치환된 2-아미노-1,2,3,4-테트라하이드로나프탈렌
FI832557A0 (fi) Nya karbacykliner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
HUP0001827A2 (hu) Kolchicin-származékok, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények, és a vegyületek alkalmazása gyógyszerkészítmények előállítására
KR960704904A (ko) 수용성 레티노이드 (Water-soluble retinoids)
ATE36539T1 (de) Antitumor-anthracycline.
SE7714464L (sv) Glykosider och forfarande for framstellning derav
DE3776572D1 (de) 14,17-g(b)-ethano-14-g(b)-estratriene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
SE8804037L (sv) Nya 4-demetoxiantracyclinderivat
FI91762C (fi) 4-substituoidut antrasyklinonit ja -antrasykliiniglykosidit ja niiden valmistaminen
IT1232343B (it) Derivati idrosolubili di bioflavonoidi di glicosidici, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
BE905751A (fr) Nitro-anthracycline, aglycone correspondante, procedes pour les preparer, composition pharmaceutique correspondante.
GB1497407A (en) Therapeutic compositions
GB1532551A (en) Furo(3,4-6)furone derivatives and their preparation
SE7708452L (sv) Komposition innehallande en antrakinonforening
SE8300324L (sv) Daunorubicin och doxorubicin-analoger, deras framstellning och anvendning
ES2095542T3 (es) Nuevos ciclopentanperhidrofenantren-17beta-(hidroxi o alcoxi)-17alfa-(aril o heterociclil)-3beta-derivados activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.
Glaudemans The specific substance from Diplococcus pneumoniae type 34 US type 41).: Synthesis of methyl 3-O-β-d-galactofuranosyl-α-d-glucopyranoside
ES8307789A1 (es) "un procedimiento para la preparacion de derivados de piridina y pirrolidina".